Silychristin

Silychristin at a Glance

Silychristin is a flavonolignan making up roughly 15–25% of milk thistle’s silymarin complex, and typically its strongest direct radical scavenger — outperforming silybin in antioxidant assays, despite silybin getting most of the attention.

Its most distinctive property is unrelated to the liver: it is a potent inhibitor of the thyroid hormone transporter MCT8, which is a genuine and specific pharmacological finding, and one worth knowing given milk thistle’s ubiquity.

What It's Used For

Silychristin is a flavonolignan of the silymarin complex from milk thistle seed — a sibling of the dominant silybin (silibinin) and of isosilybin, at roughly 15–25% of the mixture. It has a genuine dual identity. First, it is typically the strongest direct radical scavenger of the common flavonolignans, out-scoring silybin in antioxidant assays ^{3Reference 3Sersen F et al. · 2006Silymarin and its components scavenge phenylglyoxylic ketyl radicalsView study →}.

Second, and most distinctively, it is a potent, selective inhibitor of MCT8 (SLC16A2), the transporter that carries thyroid hormone across cell membranes ^{2Reference 2Johannes J et al. · 2016Silychristin, a flavonolignan derived from milk thistle, is a potent inhibitor of the thyroid-hormone transporter MCT8View study →} — which makes it a research tool and a theoretical thyroid-axis caution. As with the other congeners, milk thistle’s clinical evidence rests on the silymarin complex/silibinin, not isolated silychristin.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. No human isolate data, so scores stay low by design.

01Antioxidant / radical scavengingShaky38%Direct assays where silychristin outperforms silybin ^{1,3Reference 1Selc M · 2025Looking beyond silybin: the importance of other silymarin flavonolignansView study →Reference 3Sersen F et al. · 2006Silymarin and its components scavenge phenylglyoxylic ketyl radicalsView study →}

02Hepatoprotective / cytoprotectiveShaky26%Flavonolignan-class cytoprotection (complex-level) ^{4,5Reference 4Vostálová J et al. · 2019Skin-protective activity of silymarin and its flavonolignansView study →Reference 5Chlopčíková Š et al. · 2004AnimalChemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes: silymarin and its flavonolignansView study →}

03MCT8 inhibition (research tool / caveat)Shaky24%Potent, selective MCT8 inhibition in vitro ^{2Reference 2Johannes J et al. · 2016Silychristin, a flavonolignan derived from milk thistle, is a potent inhibitor of the thyroid-hormone transporter MCT8View study →}

Mechanisms

Pharmacokinetics

Silychristin shares the flavonolignan class’s poor aqueous solubility and poor oral bioavailability — the seed complex is not water-soluble, so teas do not deliver a meaningful dose, and standardized extracts or phospholipid complexes are used for the parent complex ^{1Reference 1Selc M · 2025Looking beyond silybin: the importance of other silymarin flavonolignansView study →}. There is no dedicated human pharmacokinetic study of the isolate, so low systemic exposure from oral intake should be assumed — and importantly, the ~100 nM in-vitro MCT8 potency is a cell-assay figure, not an achieved plasma concentration.

Clinical trials

There are no human trials of isolated silychristin. All human evidence associated with milk thistle is on the silymarin complex or silibinin/silybin (NAFLD, chronic liver disease, IV Legalon SIL for Amanita poisoning), not this single molecule — those outcomes must not be presented as silychristin efficacy.

Last checked: July 2026.

Toxicity & Safety

Silychristin itself shows no sign of intrinsic toxicity, but it carries one distinctive flag that no other milk-thistle flavonolignan does — potent, selective inhibition of the thyroid-hormone transporter MCT8.

Safety at a Glance

✅ Low / no toxicityAllergy risk

• No signal of intrinsic toxicity. It normally reaches humans only as a minor fraction of a well-tolerated seed extract.
• Selective MCT8 inhibitor. Loss-of-function mutations in this thyroid-hormone transporter cause a severe neurodevelopmental disorder.
• Avoid the purified isolate in pregnancy. Fetal-brain thyroid-hormone transport is the concern.
• The thyroid concern is theoretical at normal oral intake. Bioavailability is poor and achieved concentrations are likely well below the in-vitro IC50.
• Asteraceae allergy. The usual milk-thistle-product caution applies.

Full Safety & Interactions Detail

Silychristin has a low toxicity verdict for the flavonolignan itself — no signal of intrinsic toxicity, and it reaches humans normally only as a minor fraction of a well-tolerated seed extract. The distinctive concern that must be flagged is MCT8 inhibition: silychristin is a potent and unusually selective inhibitor of the transporter that carries thyroid hormone (T3/T4) across cell membranes, and loss-of-function MCT8 mutations cause a severe neurodevelopmental disorder ^{2Reference 2Johannes J et al. · 2016Silychristin, a flavonolignan derived from milk thistle, is a potent inhibitor of the thyroid-hormone transporter MCT8View study →}.

In principle meaningful MCT8 inhibition could perturb tissue-level thyroid-hormone distribution — this remains theoretical for normal oral intake (bioavailability is poor and achieved concentrations are likely well below the in-vitro IC50), but it is a genuine, well-cited property, so the rating is low with an explicit thyroid-axis caveat rather than unqualified. Asteraceae-allergy caution applies to milk-thistle products generally.

Dosage

There is no established therapeutic dose — silychristin is not sold or dosed as an isolate and is consumed only as ~15–25% of a standardized silymarin extract, so no dosing recommendation can be made and any figure would be extrapolation from the complex.

References

1. Selc M, Babelova A (2025). Looking beyond silybin: the importance of other silymarin flavonolignans. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/40761399/
2. Johannes J, et al. (2016). Silychristin, a flavonolignan derived from milk thistle, is a potent inhibitor of the thyroid-hormone transporter MCT8. Endocrinology. https://pubmed.ncbi.nlm.nih.gov/26910310/
3. Sersen F, et al. (2006). Silymarin and its components scavenge phenylglyoxylic ketyl radicals. Fitoterapia. https://pubmed.ncbi.nlm.nih.gov/16956731/
4. Vostálová J, et al. (2019). Skin-protective activity of silymarin and its flavonolignans. Molecules. https://pubmed.ncbi.nlm.nih.gov/30875758/
5. Chlopčíková Š, et al. (2004). Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes: silymarin and its flavonolignans. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/15022159/